Harry van Dijken - Concepedia

Author

Harry van Dijken

National Institute for Public Health and the Environment ORCID

Also Known As

H DIJKEN, H van Dijken, H. van Dijken, Harry van Dijken

Publications

907

Citations

H-Index

Concepts

All Affiliations

National Institute for Public Health and the Environment Utrecht University Institute of Experimental Medicine Wageningen University & Research TuBerculosis Vaccine Initiative

About

Harry van Dijken is an author at National Institute for Public Health and the Environment specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	715
2	Health Sciences	1	1	30
3	Natural Sciences	1	1	27
4	Allergy	1	1	30
5	Biochemistry	1	1	27

Harry van Dijken

Publications

884

Citations

H-Index

Page 1

	Year	Citations
Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process Bas van de Waterbeemd, Mathieu Streefland, Peter van der Ley, Vaccine VaccinationReverse VaccinologyVaccine ResearchOmv VaccineVaccine Target	2010	184
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age Ester D. de Kleijn, Ronald de Groot, Jerry Labadie, Vaccine VaccinologyVaccinationVaccine DevelopmentImmunologyInfection Control	2000	138
Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine E R van der Voort, Peter van der Ley, J van der Biezen, Infection and Immunity ImmunologyBacteriologyMolecular BiologyEscherichia ColiPora P1.7,16	1996	104
A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets Koen van de Ven, Josien Lanfermeijer, Harry van Dijken, Science Advances	2022	61
Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine Ester D. de Kleijn, Lilian van Eijndhoven, Clementien L. Vermont, Vaccine VaccinationVaccinologySerum Bactericidal ActivityIsotype DistributionMucosal Vaccination	2001	49
H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets Jørgen de Jonge, Harry van Dijken, Femke de Heij, npj Vaccines	2020	39
Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine E R van der Voort, Harry van Dijken, Betsy Kuipers, Infection and Immunity Potential Vaccine CandidateImmunologyImmunodominanceHuman B-Cd4 T Cell Responses	1997	38
Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets Sietske K. Rosendahl Huber, Marcel Camps, Ronald Jacobi, PLoS ONE VaccinationCross-protectionB Epitope VaccineVaccine DevelopmentVaccine Target	2015	35
H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets Jørgen de Jonge, Irina Isakova–Sivak, Harry van Dijken, Molecular Therapy VaccinationUniversal Influenza VaccineSpecies BarrierVaccine DevelopmentHighly Immunogenic	2016	34
A New Rat Model of Otitis Media Caused by <i>Streptococcus pneumoniae</i> : Conditions and Application in Immunization Protocols Leo T.M. van der Ven, Germie P. J. M. van den Dobbelsteen, Bhawani Nagarajah, Infection and Immunity Microbial PathogensHumoral ResponseImmunologyMedical MicrobiologyNew Rat Model	1999	30

Page 1